Form 10-Q
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
HEALTHEQUITY, INC.
|
||
|
|
|
Delaware
|
|
7389
|
|
52-2383166
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common stock, par value $0.0001 per share
|
HQY
|
The NASDAQ Global Select Market
|
Large accelerated filer
|
þ
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
¨
|
|
|
Emerging growth Company
|
¨
|
|
|
|
Page
|
Part I. FINANCIAL INFORMATION
|
|
|
Item 1.
|
|
|
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
Part II. OTHER INFORMATION
|
|
|
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
|
(in thousands, except par value)
|
April 30, 2019
|
|
|
January 31, 2019
|
|
||
|
(unaudited)
|
|
|
|
|||
Assets
|
|
|
|
||||
Current assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
329,310
|
|
|
$
|
361,475
|
|
Accounts receivable, net of allowance for doubtful accounts as of April 30, 2019 and January 31, 2019 of $111 and $125, respectively
|
27,022
|
|
|
25,668
|
|
||
Other current assets
|
8,244
|
|
|
7,534
|
|
||
Total current assets
|
364,576
|
|
|
394,677
|
|
||
Other investments
|
78,065
|
|
|
709
|
|
||
Property and equipment, net
|
8,481
|
|
|
8,223
|
|
||
Operating lease right-of-use assets
|
37,367
|
|
|
—
|
|
||
Intangible assets, net
|
81,437
|
|
|
79,666
|
|
||
Goodwill
|
4,651
|
|
|
4,651
|
|
||
Deferred tax asset
|
551
|
|
|
1,677
|
|
||
Other assets
|
21,511
|
|
|
20,413
|
|
||
Total assets
|
$
|
596,639
|
|
|
$
|
510,016
|
|
Liabilities and stockholders’ equity
|
|
|
|
||||
Current liabilities
|
|
|
|
||||
Accounts payable
|
$
|
1,964
|
|
|
$
|
3,520
|
|
Accrued compensation
|
8,501
|
|
|
16,981
|
|
||
Accrued liabilities
|
9,127
|
|
|
8,552
|
|
||
Operating lease liabilities
|
3,786
|
|
|
—
|
|
||
Total current liabilities
|
23,378
|
|
|
29,053
|
|
||
Operating lease liabilities, non-current
|
36,243
|
|
|
—
|
|
||
Deferred tax liability
|
7,332
|
|
|
916
|
|
||
Other long-term liabilities
|
387
|
|
|
2,968
|
|
||
Total liabilities
|
67,340
|
|
|
32,937
|
|
||
Commitments and contingencies (see note 6)
|
|
|
|
||||
Stockholders’ equity
|
|
|
|
||||
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of April 30, 2019 and January 31, 2019, respectively
|
—
|
|
|
—
|
|
||
Common stock, $0.0001 par value, 900,000 shares authorized, 62,718 and 62,446 shares issued and outstanding as of April 30, 2019 and January 31, 2019, respectively
|
6
|
|
|
6
|
|
||
Additional paid-in capital
|
315,621
|
|
|
305,223
|
|
||
Accumulated earnings
|
213,672
|
|
|
171,850
|
|
||
Total stockholders’ equity
|
529,299
|
|
|
477,079
|
|
||
Total liabilities and stockholders’ equity
|
$
|
596,639
|
|
|
$
|
510,016
|
|
(in thousands, except per share data)
|
Three months ended April 30,
|
|
|||||
2019
|
|
|
2018
|
|
|||
Revenue:
|
|
|
|
||||
Service revenue
|
$
|
26,808
|
|
|
$
|
24,821
|
|
Custodial revenue
|
41,952
|
|
|
28,434
|
|
||
Interchange revenue
|
18,292
|
|
|
16,649
|
|
||
Total revenue
|
87,052
|
|
|
69,904
|
|
||
Cost of revenue:
|
|
|
|
||||
Service costs
|
20,649
|
|
|
18,047
|
|
||
Custodial costs
|
4,123
|
|
|
3,439
|
|
||
Interchange costs
|
4,527
|
|
|
4,062
|
|
||
Total cost of revenue
|
29,299
|
|
|
25,548
|
|
||
Gross profit
|
57,753
|
|
|
44,356
|
|
||
Operating expenses:
|
|
|
|
||||
Sales and marketing
|
8,970
|
|
|
6,860
|
|
||
Technology and development
|
10,905
|
|
|
7,979
|
|
||
General and administrative
|
8,709
|
|
|
7,507
|
|
||
Amortization of acquired intangible assets
|
1,491
|
|
|
1,470
|
|
||
Total operating expenses
|
30,075
|
|
|
23,816
|
|
||
Income from operations
|
27,678
|
|
|
20,540
|
|
||
Other income (expense), net
|
23,600
|
|
|
(1
|
)
|
||
Income before income taxes
|
51,278
|
|
|
20,539
|
|
||
Income tax provision (benefit)
|
9,456
|
|
|
(2,038
|
)
|
||
Net income and comprehensive income
|
$
|
41,822
|
|
|
$
|
22,577
|
|
Net income per share:
|
|
|
|
||||
Basic
|
$
|
0.67
|
|
|
$
|
0.37
|
|
Diluted
|
$
|
0.65
|
|
|
$
|
0.36
|
|
Weighted-average number of shares used in computing net income per share:
|
|
|
|
||||
Basic
|
62,326
|
|
|
61,170
|
|
||
Diluted
|
63,901
|
|
|
62,693
|
|
(in thousands)
|
Three months ended April 30,
|
|
|||||
2019
|
|
|
2018
|
|
|||
Total stockholders' equity, beginning balances (audited)
|
$
|
477,079
|
|
|
$
|
346,274
|
|
|
|
|
|
||||
Common stock:
|
|
|
|
||||
Beginning balance
|
6
|
|
|
6
|
|
||
Issuance of common stock upon exercise of stock options, and for restricted stock
|
—
|
|
|
—
|
|
||
Ending balance
|
6
|
|
|
6
|
|
||
Additional paid-in capital:
|
|
|
|
||||
Beginning balance
|
305,223
|
|
|
261,237
|
|
||
Issuance of common stock upon exercise of stock options, and for restricted stock
|
4,370
|
|
|
10,964
|
|
||
Stock-based compensation
|
6,028
|
|
|
4,239
|
|
||
Ending balance
|
315,621
|
|
|
276,440
|
|
||
Accumulated comprehensive loss:
|
|
|
|
||||
Beginning balance
|
—
|
|
|
(269
|
)
|
||
Cumulative effect from adoption of ASU 2016-01
|
—
|
|
|
269
|
|
||
Ending balance
|
—
|
|
|
—
|
|
||
Accumulated earnings:
|
|
|
|
||||
Beginning balance
|
171,850
|
|
|
85,300
|
|
||
Net income
|
41,822
|
|
|
22,577
|
|
||
Cumulative effect from adoption of ASC 606
|
—
|
|
|
13,007
|
|
||
Cumulative effect from adoption of ASU 2016-01
|
—
|
|
|
(356
|
)
|
||
Ending balance
|
$
|
213,672
|
|
|
$
|
120,528
|
|
|
|
|
|
||||
Total stockholders' equity, ending balances
|
$
|
529,299
|
|
|
$
|
396,974
|
|
|
Three months ended April 30,
|
|
|||||
(in thousands)
|
2019
|
|
|
2018
|
|
||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
41,822
|
|
|
$
|
22,577
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
4,773
|
|
|
4,520
|
|
||
Unrealized (gains) losses on marketable equity securities and other
|
(23,484
|
)
|
|
140
|
|
||
Deferred taxes
|
7,542
|
|
|
1,989
|
|
||
Stock-based compensation
|
6,028
|
|
|
4,239
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
Accounts receivable
|
(1,354
|
)
|
|
(1,420
|
)
|
||
Other assets
|
(1,694
|
)
|
|
(5,471
|
)
|
||
Operating lease right-of-use assets
|
635
|
|
|
—
|
|
||
Accounts payable
|
(1,577
|
)
|
|
87
|
|
||
Accrued compensation
|
(8,480
|
)
|
|
(4,909
|
)
|
||
Accrued liabilities and other current liabilities
|
1,769
|
|
|
881
|
|
||
Operating lease liabilities, non-current
|
(627
|
)
|
|
—
|
|
||
Other long-term liabilities
|
(17
|
)
|
|
71
|
|
||
Net cash provided by operating activities
|
25,336
|
|
|
22,704
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of intangible member assets
|
(1,262
|
)
|
|
—
|
|
||
Purchases of marketable equity securities
|
(53,845
|
)
|
|
(180
|
)
|
||
Purchases of property and equipment
|
(1,126
|
)
|
|
(1,121
|
)
|
||
Purchases of software and capitalized software development costs
|
(5,497
|
)
|
|
(2,097
|
)
|
||
Net cash used in investing activities
|
(61,730
|
)
|
|
(3,398
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from exercise of common stock options
|
4,229
|
|
|
10,167
|
|
||
Net cash provided by financing activities
|
4,229
|
|
|
10,167
|
|
||
Increase (decrease) in cash and cash equivalents
|
(32,165
|
)
|
|
29,473
|
|
||
Beginning cash and cash equivalents
|
361,475
|
|
|
199,472
|
|
||
Ending cash and cash equivalents
|
$
|
329,310
|
|
|
$
|
228,945
|
|
Supplemental cash flow data:
|
|
|
|
||||
Interest expense paid in cash
|
$
|
50
|
|
|
$
|
50
|
|
Income taxes paid in cash, net of refunds received
|
(51
|
)
|
|
39
|
|
||
Supplemental disclosures of non-cash investing and financing activities:
|
|
|
|
||||
Purchases of property and equipment included in accounts payable or accrued liabilities at period end
|
$
|
21
|
|
|
$
|
491
|
|
Purchases of software and capitalized software development costs included in accounts payable or accrued liabilities at period end
|
158
|
|
|
117
|
|
||
Exercise of common stock options receivable
|
141
|
|
|
797
|
|
(in thousands, except per share data)
|
|
Three months ended April 30,
|
|
|||||
|
2019
|
|
|
2018
|
|
|||
Numerator (basic and diluted):
|
|
|
|
|
||||
Net income
|
|
$
|
41,822
|
|
|
$
|
22,577
|
|
Denominator (basic):
|
|
|
|
|
||||
Weighted-average common shares outstanding
|
|
62,326
|
|
|
61,170
|
|
||
Denominator (diluted):
|
|
|
|
|
||||
Weighted-average common shares outstanding
|
|
62,326
|
|
|
61,170
|
|
||
Weighted-average dilutive effect of stock options and restricted stock units
|
|
1,575
|
|
|
1,523
|
|
||
Diluted weighted-average common shares outstanding
|
|
63,901
|
|
|
62,693
|
|
||
Net income per share:
|
|
|
|
|
||||
Basic
|
|
$
|
0.67
|
|
|
$
|
0.37
|
|
Diluted
|
|
$
|
0.65
|
|
|
$
|
0.36
|
|
(in thousands)
|
|
April 30, 2019
|
|
|
January 31, 2019
|
|
||
Leasehold improvements
|
|
$
|
3,753
|
|
|
$
|
3,583
|
|
Furniture and fixtures
|
|
4,828
|
|
|
4,476
|
|
||
Computer equipment
|
|
9,839
|
|
|
9,242
|
|
||
Property and equipment, gross
|
|
18,420
|
|
|
17,301
|
|
||
Accumulated depreciation
|
|
(9,939
|
)
|
|
(9,078
|
)
|
||
Property and equipment, net
|
|
$
|
8,481
|
|
|
$
|
8,223
|
|
(in thousands)
|
|
April 30, 2019
|
|
|
January 31, 2019
|
|
||
Marketable equity securities, at fair value
|
|
$
|
77,356
|
|
|
$
|
—
|
|
Non-marketable equity securities
|
|
500
|
|
|
500
|
|
||
Equity method investments
|
|
209
|
|
|
209
|
|
||
Total equity investments
|
|
$
|
78,065
|
|
|
$
|
709
|
|
|
|
Three months ended April 30,
|
|
|||||
(in thousands)
|
|
2019
|
|
|
2018
|
|
||
Interest income, net
|
|
$
|
1,280
|
|
|
$
|
191
|
|
Unrealized gain on marketable equity securities
|
|
23,511
|
|
|
—
|
|
||
Acquisition-related costs
|
|
(1,184
|
)
|
|
(1
|
)
|
||
Other
|
|
(7
|
)
|
|
(191
|
)
|
||
Total other income (expense), net
|
|
$
|
23,600
|
|
|
$
|
(1
|
)
|
|
|
Three months ended
|
|
|
(in thousands, except for term and percentages)
|
|
April 30, 2019
|
|
|
Operating lease expense
|
|
$
|
1,074
|
|
Weighted average remaining lease term
|
|
11.49 years
|
|
|
Weighted average discount rate
|
|
4.37
|
%
|
Fiscal year ending January 31, (in thousands)
|
|
Operating leases
|
|
|
Remaining 2020
|
|
$
|
2,865
|
|
2021
|
|
4,105
|
|
|
2022
|
|
4,205
|
|
|
2023
|
|
4,233
|
|
|
2024
|
|
4,288
|
|
|
Thereafter
|
|
31,930
|
|
|
Total lease payments
|
|
51,626
|
|
|
Less imputed interest
|
|
(11,597
|
)
|
|
Present value of lease liabilities
|
|
$
|
40,029
|
|
|
|
|
||
Current
|
|
$
|
3,786
|
|
Non-current
|
|
36,243
|
|
|
Total lease liabilities
|
|
$
|
40,029
|
|
|
|
Three months ended
|
|
|
(in thousands)
|
|
April 30, 2019
|
|
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|
|
||
Operating cash flows from operating leases
|
|
$
|
977
|
|
ROU assets obtained in exchange for new operating lease obligations
|
|
$
|
199
|
|
(in thousands)
|
|
April 30, 2019
|
|
|
January 31, 2019
|
|
||
Amortized intangible assets:
|
|
|
|
|
||||
Capitalized software development costs
|
|
$
|
44,328
|
|
|
$
|
40,583
|
|
Software
|
|
6,162
|
|
|
4,252
|
|
||
Other intangible assets
|
|
2,882
|
|
|
2,882
|
|
||
Acquired intangible member assets
|
|
85,110
|
|
|
85,110
|
|
||
Intangible assets, gross
|
|
138,482
|
|
|
132,827
|
|
||
Accumulated amortization
|
|
(57,045
|
)
|
|
(53,161
|
)
|
||
Intangible assets, net
|
|
$
|
81,437
|
|
|
$
|
79,666
|
|
|
|
Three months ended April 30,
|
|
|||||
(in thousands)
|
|
2019
|
|
|
2018
|
|
||
Cost of revenue
|
|
$
|
860
|
|
|
$
|
413
|
|
Sales and marketing
|
|
1,007
|
|
|
705
|
|
||
Technology and development
|
|
1,499
|
|
|
991
|
|
||
General and administrative
|
|
2,662
|
|
|
2,130
|
|
||
Total stock-based compensation expense
|
|
$
|
6,028
|
|
|
$
|
4,239
|
|
|
|
Three months ended April 30,
|
|
|||||
(in thousands)
|
|
2019
|
|
|
2018
|
|
||
Stock options
|
|
$
|
1,783
|
|
|
$
|
1,764
|
|
Performance stock options
|
|
—
|
|
|
153
|
|
||
Restricted stock units
|
|
2,926
|
|
|
1,542
|
|
||
Performance restricted stock units
|
|
651
|
|
|
514
|
|
||
Restricted stock awards
|
|
163
|
|
|
55
|
|
||
Performance restricted stock awards
|
|
505
|
|
|
211
|
|
||
Total stock-based compensation expense
|
|
$
|
6,028
|
|
|
$
|
4,239
|
|
|
|
Three months ended April 30,
|
|
|||
|
|
2019
|
|
|
2018
|
|
Expected dividend yield
|
|
—
|
%
|
|
—
|
%
|
Expected stock price volatility
|
|
35.98% - 36.53%
|
|
|
37.84
|
%
|
Risk-free interest rate
|
|
2.21% - 2.43%
|
|
|
2.52% - 2.68%
|
|
Expected life of options
|
|
4.95 - 5.09 years
|
|
|
5.17 - 6.25 years
|
|
|
|
Outstanding stock options
|
|
||||||||||||
(in thousands, except for exercise prices and term)
|
|
Number of
options |
|
|
Range of
exercise prices |
|
Weighted-
average exercise price |
|
|
Weighted-
average contractual term (in years) |
|
Aggregate
intrinsic value |
|
||
Outstanding as of January 31, 2019
|
|
2,444
|
|
|
$0.10 - 82.39
|
|
$
|
27.37
|
|
|
6.74
|
|
$
|
85,971
|
|
Granted
|
|
108
|
|
|
$63.64 - 73.61
|
|
$
|
73.27
|
|
|
|
|
|
||
Exercised
|
|
(178
|
)
|
|
$0.10 - 44.53
|
|
$
|
24.49
|
|
|
|
|
|
||
Forfeited
|
|
(18
|
)
|
|
$24.36 - 44.53
|
|
$
|
30.92
|
|
|
|
|
|
||
Outstanding as of April 30, 2019
|
|
2,356
|
|
|
$0.10 - 82.39
|
|
$
|
29.66
|
|
|
6.62
|
|
$
|
90,701
|
|
Vested and expected to vest as of April 30, 2019
|
|
2,356
|
|
|
|
|
$
|
29.66
|
|
|
6.62
|
|
$
|
90,701
|
|
Exercisable as of April 30, 2019
|
|
1,503
|
|
|
|
|
$
|
21.82
|
|
|
5.91
|
|
$
|
69,042
|
|
|
|
RSUs and PRSUs
|
|
|
RSAs and PRSAs
|
|
||||||||
(in thousands, except weighted-average grant date fair value)
|
|
Shares
|
|
|
Weighted-average grant date fair value
|
|
|
Shares
|
|
|
Weighted-average grant date fair value
|
|
||
Outstanding as of January 31, 2019
|
|
648
|
|
|
$
|
55.20
|
|
|
256
|
|
|
$
|
61.93
|
|
Granted
|
|
421
|
|
|
73.02
|
|
|
—
|
|
|
—
|
|
||
Vested
|
|
(94
|
)
|
|
52.35
|
|
|
(11
|
)
|
|
62.75
|
|
||
Forfeited
|
|
(19
|
)
|
|
54.48
|
|
|
(10
|
)
|
|
61.72
|
|
||
Outstanding as of April 30, 2019
|
|
956
|
|
|
$
|
63.33
|
|
|
235
|
|
|
$
|
61.91
|
|
•
|
Level 1—quoted prices in active markets for identical assets or liabilities;
|
•
|
Level 2—inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
|
•
|
Level 3—unobservable inputs based on the Company’s own assumptions.
|
|
|
April 30, 2019
|
|
|||||||||
(in thousands)
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|||
Other investments:
|
|
|
|
|
|
|
|
|||||
Marketable equity securities
|
|
$
|
77,356
|
|
|
$
|
—
|
|
|
$
|
—
|
|
(in millions, except percentages)
|
|
April 30, 2019
|
|
|
April 30, 2018
|
|
|
% Change
|
|
|
January 31, 2019
|
|
HSA Members
|
|
4,054
|
|
|
3,476
|
|
|
17
|
%
|
|
3,994
|
|
Average HSA Members - Year-to-date
|
|
4,026
|
|
|
3,444
|
|
|
17
|
%
|
|
3,608
|
|
Average HSA Members - Quarter-to-date
|
|
4,026
|
|
|
3,444
|
|
|
17
|
%
|
|
3,813
|
|
New HSA Members - Year-to-date
|
|
89
|
|
|
98
|
|
|
(9
|
)%
|
|
679
|
|
New HSA Members - Quarter-to-date
|
|
89
|
|
|
98
|
|
|
(9
|
)%
|
|
341
|
|
Active HSA Members
|
|
3,245
|
|
|
2,882
|
|
|
13
|
%
|
|
3,241
|
|
HSA Members with investments
|
|
177
|
|
|
134
|
|
|
32
|
%
|
|
163
|
|
(in millions, except percentages)
|
|
April 30, 2019
|
|
|
April 30, 2018
|
|
|
% Change
|
|
|
January 31, 2019
|
|
|||
Custodial cash
|
|
$
|
6,404
|
|
|
$
|
5,511
|
|
|
16
|
%
|
|
$
|
6,428
|
|
Custodial investments
|
|
1,917
|
|
|
1,351
|
|
|
42
|
%
|
|
1,670
|
|
|||
Total custodial assets
|
|
$
|
8,321
|
|
|
$
|
6,862
|
|
|
21
|
%
|
|
$
|
8,098
|
|
Average daily custodial cash - Year-to-date
|
|
$
|
6,407
|
|
|
$
|
5,467
|
|
|
17
|
%
|
|
$
|
5,586
|
|
Average daily custodial cash - Quarter-to-date
|
|
$
|
6,407
|
|
|
$
|
5,467
|
|
|
17
|
%
|
|
$
|
5,837
|
|
|
|
Three months ended April 30,
|
|
|||||
(in thousands)
|
|
2019
|
|
|
2018
|
|
||
Net income
|
|
$
|
41,822
|
|
|
$
|
22,577
|
|
Interest income
|
|
(1,343
|
)
|
|
(258
|
)
|
||
Interest expense
|
|
63
|
|
|
67
|
|
||
Income tax provision (benefit)
|
|
9,456
|
|
|
(2,038
|
)
|
||
Depreciation and amortization
|
|
3,282
|
|
|
3,050
|
|
||
Amortization of acquired intangible assets
|
|
1,491
|
|
|
1,470
|
|
||
Stock-based compensation expense
|
|
6,028
|
|
|
4,239
|
|
||
Unrealized gain on marketable equity securities
|
|
(23,511
|
)
|
|
—
|
|
||
Other (1)
|
|
1,635
|
|
|
520
|
|
||
Adjusted EBITDA
|
|
$
|
38,923
|
|
|
$
|
29,627
|
|
(1)
|
For the three months ended
April 30, 2019
and
2018
, Other consisted of non-income-based taxes of
$13
and $104, other (income)/costs of
$(6)
and $88, acquisition-related costs of
$1,184
and $1, and amortization of incremental costs to obtain a contract of
$444
and $327, respectively.
|
|
Three months ended April 30,
|
|
|
|
|||||||
(in thousands, except percentages)
|
2019
|
|
2018
|
|
$ Change
|
|
% Change
|
|
|||
Adjusted EBITDA
|
$
|
38,923
|
|
$
|
29,627
|
|
$
|
9,296
|
|
31
|
%
|
As a percentage of revenue
|
45
|
%
|
42
|
%
|
|
|
|
|
Three months ended April 30,
|
|
|
|
|
|
||||||||
(in thousands, except percentages)
|
|
2019
|
|
|
2018
|
|
|
$ Change
|
|
|
% Change
|
|
|||
Service revenue
|
|
$
|
26,808
|
|
|
$
|
24,821
|
|
|
$
|
1,987
|
|
|
8
|
%
|
Custodial revenue
|
|
41,952
|
|
|
28,434
|
|
|
13,518
|
|
|
48
|
%
|
|||
Interchange revenue
|
|
18,292
|
|
|
16,649
|
|
|
1,643
|
|
|
10
|
%
|
|||
Total revenue
|
|
$
|
87,052
|
|
|
$
|
69,904
|
|
|
$
|
17,148
|
|
|
25
|
%
|
(in thousands, except percentages)
|
|
Three months ended April 30,
|
|
|
|
|
|
||||||||
|
2019
|
|
|
2018
|
|
|
$ Change
|
|
|
% Change
|
|
||||
Service costs
|
|
$
|
20,649
|
|
|
$
|
18,047
|
|
|
$
|
2,602
|
|
|
14
|
%
|
Custodial costs
|
|
4,123
|
|
|
3,439
|
|
|
684
|
|
|
20
|
%
|
|||
Interchange costs
|
|
4,527
|
|
|
4,062
|
|
|
465
|
|
|
11
|
%
|
|||
Total cost of revenue
|
|
$
|
29,299
|
|
|
$
|
25,548
|
|
|
$
|
3,751
|
|
|
15
|
%
|
(in thousands, except percentages)
|
|
Three months ended April 30,
|
|
|
|
|
|
||||||||
|
2019
|
|
|
2018
|
|
|
$ Change
|
|
|
% Change
|
|
||||
Sales and marketing
|
|
$
|
8,970
|
|
|
$
|
6,860
|
|
|
$
|
2,110
|
|
|
31
|
%
|
Technology and development
|
|
10,905
|
|
|
7,979
|
|
|
2,926
|
|
|
37
|
%
|
|||
General and administrative
|
|
8,709
|
|
|
7,507
|
|
|
1,202
|
|
|
16
|
%
|
|||
Amortization of acquired intangible assets
|
|
1,491
|
|
|
1,470
|
|
|
21
|
|
|
1
|
%
|
|||
Total operating expenses
|
|
$
|
30,075
|
|
|
$
|
23,816
|
|
|
$
|
6,259
|
|
|
26
|
%
|
|
|
Three months ended April 30,
|
|
|||||
(in thousands)
|
|
2019
|
|
|
2018
|
|
||
Net cash provided by operating activities
|
|
$
|
25,336
|
|
|
$
|
22,704
|
|
Net cash used in investing activities
|
|
(61,730
|
)
|
|
(3,398
|
)
|
||
Net cash provided by financing activities
|
|
4,229
|
|
|
10,167
|
|
||
Increase (decrease) in cash and cash equivalents
|
|
(32,165
|
)
|
|
29,473
|
|
||
Beginning cash and cash equivalents
|
|
361,475
|
|
|
199,472
|
|
||
Ending cash and cash equivalents
|
|
$
|
329,310
|
|
|
$
|
228,945
|
|
|
|
|
Incorporate by reference
|
|||
Exhibit
no.
|
|
Description
|
Form
|
File No.
|
Exhibit
|
Filing Date
|
10.1+
|
|
|
|
|
|
|
31.1+
|
|
|
|
|
|
|
31.2+
|
|
|
|
|
|
|
32.1*#
|
|
|
|
|
|
|
32.2*#
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance document
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy schema linkbase document
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy calculation linkbase document
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy definition linkbase document
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy labels linkbase document
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy presentation linkbase document
|
|
|
|
|
+
|
|
Filed herewith.
|
*
|
|
Furnished herewith.
|
#
|
|
These certifications are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference in any filing the registrant makes under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, irrespective of any general incorporation language in any filings.
|
|
HEALTHEQUITY, INC.
|
||
Date: June 6, 2019
|
By:
|
|
/s/ Darcy Mott
|
|
Name:
|
|
Darcy Mott
|
|
Title:
|
|
Executive Vice President and Chief Financial Officer
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of HealthEquity, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
By:
|
|
/s/ Jon Kessler
|
Name:
|
|
Jon Kessler
|
Title:
|
|
Chief Executive Officer
(Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of HealthEquity, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
By:
|
|
/s/ Darcy Mott
|
Name:
|
|
Darcy Mott
|
Title:
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|
1.
|
Our Quarterly Report on Form 10-Q for the quarter ended
April 30, 2019
(the “Report”), of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
By:
|
|
/s/ Jon Kessler
|
Name:
|
|
Jon Kessler
|
Title:
|
|
Chief Executive Officer
(Principal Executive Officer)
|
1.
|
Our Quarterly Report on Form 10-Q for the quarter ended
April 30, 2019
(the “Report”), of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
By:
|
|
/s/ Darcy Mott
|
Name:
|
|
Darcy Mott
|
Title:
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|